Oral Antidiabetic Drugs Market by Drugs Class Category (Sulfonylureas, Meglitinides, Biguanides and Alpha-glucosidase inhibitors) for Type 2 Diabetes mellitus - Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022

Global oral antidiabetic drug market is expected to reach USD 35.91 billion by 2022, growing at a CAGR of 10.2% between 2017 and 2022.

06-Jan-2017 | Number of pages: 110 | Report Code: ZMR-687 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the oral antidiabetic drugs market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based on revenue (USD billion). The study includes drivers and restraints of the oral antidiabetic drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the oral antidiabetic drugs market on a global level.

In order to give the users a comprehensive view of the Oral antidiabetic drugs market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the oral antidiabetic drugs market has also been included. The study encompasses a market attractiveness analysis, wherein the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the oral antidiabetic drugs market by segmenting the market based on drugs class and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022. The drugs class segmentation includes sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. The meglitinides class is further segmented into repaglinide and nateglinide. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. These regions are further sub-segmented into U.S., Canada, China, Japan, and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global oral antidiabetic drugs market include Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck and Pfizer.

This report segments the global oral antidiabetic drugs Market as follows:

Global Oral Antidiabetic Drugs Market: Drugs Class Analysis

  • Sulfonylureas
    • Glimepiride
    •  Gliclazide
    •  Glyburide
    •  Others
  • Meglitinides
  • Repaglinide
  • Nateglinide
  • Biguanides
    • Metformin
    •  Others
  • Alpha-glucosidase inhibitors
    • Acarbose
    •  Voglibose
    •  Others
  • Others

Global Oral Antidiabetic Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Upper Respiratory Tract Treatment Infection Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1720 | Report Format:

Global Upper Respiratory Tract Treatment Infection Market: Overview One of the most common reasons for the people visiting the clinics and hospitals is upper respiratory tract infection. A contagious and acute infection that occurs in the upper respiratory tract is known as upper respiratory tra...Read More

Sickle Cell Anemia Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1712 | Report Format:

Global Sickle Cell Anemia Treatment Market: Overview A disorder of the red blood cells is sickle cell anemia. This is an inherited disease. In this disease the red blood cells have a short life thus healthy cells are scarce for transporting adequate amount of oxygen to the organs. In normal cond...Read More

Tuberculosis Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1702 | Report Format:

Global Tuberculosis Therapeutics Market: Overview Mycobacterium tuberculosis is the bacteria that cause the chronic infectious disease tuberculosis. Pulmonary tuberculosis is the alternate name for tuberculosis. In this disease, the bacteria majorly infects any part of the body, mainly it is the...Read More

Systemic Infection Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1701 | Report Format:

Global Systemic Infection Treatment Market: Overview Systemic infection is a pathogenic infection that gets affected throughout the body. It can consist of viral, bacterial, or fungal infections. Systemic infection affects the persons bloodstream and gradually spreads to the whole body. The syst...Read More

Empty Capsules Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1694 | Report Format:

Global Empty Capsules Market: Overview Empty capsules allow users to fill colorants, bulking agents, and fillers on their own in the capsule. It also permits the user to mix different ingredients together and accordingly decide the specifications of the capsules. Empty capsules are safe, cheaper...Read More

Choose License Type: